Publications in VIVO

Co-author Network

Hermona Soreq, PhD

Person

Positions

Professor, The Hebrew University of Jerusalem

Location

Jerusalem, ISRAEL

Clinical Disciplines

Other

Publications
Other
View All

Selected Publications

article
1. Knockout of the longevity gene Klotho perturbs aging and Alzheimer's disease-linked brain microRNAs and tRNA fragments.. Communications biology. 7:-. 2024
2. MicroRNA guardians of the posterior cingulate cortex delay cognitive deterioration in elders.. Brain communications. 6:-. 2024
3. Boltzmann's Theorem Revisited: Inaccurate Time-to-Action Clocks in Affective Disorders.. Current neuropharmacology. 22:1762-1777. 2024
4. EDITOR SPOTLIGHT: Interview with Cholinergic Mechanisms Special Issue Guest Editor Hermona Soreq.. Journal of neurochemistry. 168:331-333. 2024
5. Ribosomal protein L24 mediates mammalian microRNA processing in an evolutionarily conserved manner.. Cellular and molecular life sciences : CMLS. 81:-. 2024
6. Lysine tRNA fragments and miR-194-5p co-regulate hepatic steatosis via β-Klotho and Perilipin 2.. Molecular metabolism. -. 2023
7. Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.. Frontiers in immunology. -. 2023
8. Recent advances in cholinergic mechanisms: A preface for the ISCM2022 special issue.. Journal of neurochemistry. 168:334-338. 2023
9. Novel single-nucleus transcriptomics unravels developmental and functionally controlled principles of mammalian neuromuscular junctions.. Journal of neurochemistry. 168:339-341. 2023
10. The Human Affectome.. Neuroscience and biobehavioral reviews. -. 2023
11. Recent advances in cholinergic mechanisms as reactions to toxicity, stress, and neuroimmune insults.. Journal of neurochemistry. 168:355-369. 2023
12. Inversely Regulated Inflammation-Related Processes Mediate Anxiety-Obesity Links in Zebrafish Larvae and Adults.. Cells. 12. 2023
13. Control systems theory revisited: new insights on the brain clocks of time-to-action.. Frontiers in neuroscience. -. 2023
14. Sex-specific declines in cholinergic-targeting tRNA fragments in the nucleus accumbens in Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 19:5159-5172. 2023
15. Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease".. Movement disorders : official journal of the Movement Disorder Society. 38:1127-1142. 2023
16. Sex-specific declines in cholinergic-targeting tRNA fragments in the nucleus accumbens in Alzheimer's disease.. bioRxiv : the preprint server for biology. 2023
17. Ageing-associated small RNA cargo of extracellular vesicles.. RNA biology. 20:482-494. 2023
18. Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex, and Parkinson's disease-related changes.. Journal of neurochemistry. 164:671-683. 2022
19. Editorial: The molecular mechanisms of epilepsy and potential therapeutics.. Frontiers in molecular neuroscience. -. 2022
20. High-throughput morphometric and transcriptomic profiling uncovers composition of naïve and sensory-deprived cortical cholinergic VIP/CHAT neurons.. The EMBO journal. 42:-. 2022
21. Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo.. Acta neuropathologica. 144:881-910. 2022
22. Chromosomal and environmental contributions to sex differences in the vulnerability to neurological and neuropsychiatric disorders: Implications for therapeutic interventions.. Progress in neurobiology. -. 2022
23. Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer's and Parkinson's disease.. Frontiers in molecular neuroscience. -. 2022
24. Biological underpinnings of sex differences in neurological disorders.. International review of neurobiology. 27-67. 2022
25. Distinct CholinomiR Blood Cell Signature as a Potential Modulator of the Cholinergic System in Women with Fibromyalgia Syndrome.. Cells. 11. 2022
26. Cholinergic blockade of neuroinflammation: from tissue to RNA regulators.. Neuronal signaling. 6:-. 2022
27. Cholinergic blockade of neuroinflammation: from tissue to RNA regulators.. Neuronal signaling. 2022
28. Preface: Cholinergic mechanisms: This is the Preface for the special issue "Cholinergic Mechanisms".. Journal of neurochemistry. 158:1212-1216. 2021
29. MicroRNA-132 may be associated with blood pressure and liver steatosis-preliminary observations in obese individuals.. Journal of human hypertension. 36:911-916. 2021
30. Regulators of cholinergic signaling in disorders of the central nervous system.. Journal of neurochemistry. 158:1425-1438. 2021
31. Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockade.. Proceedings of the National Academy of Sciences of the United States of America. 117:32606-32616. 2020
32. Establishing Human Male and Female Models of Cholinergic Neurons via Neurokine-Mediated Differentiation of LA-N-2 and LA-N-5 Neuroblastoma Cells.. STAR protocols. 1:-. 2020
33. Blood acetylcholinesterase activity is associated with increased 10 year all-cause mortality following coronary angiography.. Atherosclerosis. 144-149. 2020
34. The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.. Frontiers in immunology. -. 2020
35. Pharmaceutical Implications of Sex-Related RNA Divergence in Psychiatric Disorders.. Trends in pharmacological sciences. 41:840-850. 2020
36. A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress.. EMBO molecular medicine. 12:-. 2020
37. Cholinergic Stress Signals Accompany MicroRNA-Associated Stereotypic Behavior and Glutamatergic Neuromodulation in the Prefrontal Cortex.. Biomolecules. 10. 2020
38. Non-coding RNA regulators of diabetic polyneuropathy.. Neuroscience letters. -. 2020
39. Cholino-ncRNAs modulate sex-specific- and age-related acetylcholine signals.. FEBS letters. 594:2185-2198. 2020
40. Central and peripheral anti-inflammatory effects of acetylcholinesterase inhibitors.. Neuropharmacology. -. 2020
41. A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra.. Aging cell. 19:-. 2020
42. Barrel cortex VIP/ChAT interneurons suppress sensory responses in vivo.. PLoS biology. 18:-. 2020
43. Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease.. The Journal of neuroscience : the official journal of the Society for Neuroscience. 40:1931-1942. 2020
44. The Use of Gapmers for In Vivo Suppression of Hepatic mRNA Targets.. Methods in molecular biology (Clifton, N.J.). 177-184. 2020
45. Modulation of hippocampal neuronal resilience during aging by the Hsp70/Hsp90 co-chaperone STI1.. Journal of neurochemistry. 153:727-758. 2019
46. Integrative Transcriptomics Reveals Sexually Dimorphic Control of the Cholinergic/Neurokine Interface in Schizophrenia and Bipolar Disorder.. Cell reports. 29:764-777.e5. 2019
47. Whole blood microRNA expression associated with stroke: Results from the Framingham Heart Study.. PloS one. 14:-. 2019
48. Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome.. The EMBO journal. 38:-. 2019
49. NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 33:11223-11234. 2019
50. Current understanding of fear learning and memory in humans and animal models and the value of a linguistic approach for analyzing fear learning and memory in humans.. Neuroscience and biobehavioral reviews. 136-177. 2019
51. NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2019
52. Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function.. Brain : a journal of neurology. 141:-. 2018
53. Glial responses during epileptogenesis in Mus musculus point to potential therapeutic targets.. PloS one. 13:-. 2018
54. Victims of war-Psychoendocrine evidence for the impact of traumatic stress on psychological well-being of adolescents growing up during the Israeli-Palestinian conflict.. Psychophysiology. 57:-. 2018
55. Molecular Regulatory Pathways Link Sepsis With Metabolic Syndrome: Non-coding RNA Elements Underlying the Sepsis/Metabolic Cross-Talk.. Frontiers in molecular neuroscience. -. 2018
56. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.. Brain : a journal of neurology. 141:1320-1333. 2018
57. Intensify3D: Normalizing signal intensity in large heterogenic image stacks.. Scientific reports. 8:-. 2018
58. Genome-Wide MicroRNA Analysis Implicates miR-30b/d in the Etiology of Alopecia Areata.. The Journal of investigative dermatology. 138:549-556. 2017
59. Building Bridges through Science.. Neuron. 96:730-735. 2017
60. Alexander George Karczmar (1917-2017).. Journal of neurochemistry. 143:609-611. 2017
61. Cholinergic Surveillance over Hippocampal RNA Metabolism and Alzheimer's-Like Pathology.. Cerebral cortex (New York, N.Y. : 1991). 27:3553-3567. 2017
62. The Stress-Responding miR-132-3p Shows Evolutionarily Conserved Pathway Interactions.. Cellular and molecular neurobiology. 38:141-153. 2017
63. Alzheimer's brains show inter-related changes in RNA and lipid metabolism.. Neurobiology of disease. 1-13. 2017
64. Dynamic changes in murine forebrain miR-211 expression associate with cholinergic imbalances and epileptiform activity.. Proceedings of the National Academy of Sciences of the United States of America. 114:E4996-E5005. 2017
65. miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression.. Gut. 67:1124-1134. 2017
66. Personalized genetics of the cholinergic blockade of neuroinflammation.. Journal of neurochemistry. 142 Suppl 2:178-187. 2017
67. Antisense miR-132 blockade via the AChE-R splice variant mitigates cortical inflammation.. Scientific reports. -. 2017
68. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.. The Journal of neuroscience : the official journal of the Society for Neuroscience. 37:47-57. 2017
69. Alzheimer's Disease and ncRNAs.. Advances in experimental medicine and biology. 337-361. 2017
70. Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.. PloS one. 2017
71. Neuronal-expressed microRNA-targeted pseudogenes compete with coding genes in the human brain.. Translational psychiatry. 2017
72. CircRNAs in the brain.. RNA biology. 14:1028-1034. 2016
73. Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.. Digestive diseases and sciences. 61:3246-3254. 2016
74. MicroRNA Regulators of Anxiety and Metabolic Disorders.. Trends in molecular medicine. 22:798-812. 2016
75. Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.. PloS one. 11:-. 2016
76. Cholinergic Regulation of hnRNPA2/B1 Translation by M1 Muscarinic Receptors.. The Journal of neuroscience : the official journal of the Society for Neuroscience. 36:6287-96. 2016
77. Photocatalytic Reactive Oxygen Species Formation by Semiconductor-Metal Hybrid Nanoparticles. Toward Light-Induced Modulation of Biological Processes.. Nano letters. 16:4266-73. 2016
78. Weakened Cholinergic Blockade of Inflammation Associates with Diabetes-Related Depression.. Molecular medicine (Cambridge, Mass.). 156-161. 2016
79. Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain.. Frontiers in molecular neuroscience. -. 2016
80. Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.. Digestive diseases and sciences. 2016
81. HP1BP3 expression determines maternal behavior and offspring survival.. Genes, brain, and behavior. 2016
82. Intensified vmPFC surveillance over PTSS under perturbed microRNA-608/AChE interaction.. Translational psychiatry. 2016
83. Transcriptome profiling in Parkinson's leukocytes: from early diagnostics to neuroimmune therapeutic prospects.. Current opinion in pharmacology. 102-9. 2015
84. Analyzing alternative splicing data of splice junction arrays from Parkinson patients' leukocytes before and after deep brain stimulation as compared with control donors.. Genomics data. 340-3. 2015
85. Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagus.. Journal of neurophysiology. 114:1513-20. 2015
86. Checks and balances on cholinergic signaling in brain and body function.. Trends in neurosciences. 38:448-58. 2015
87. MicroRNA-target interactions in neurodegenerative diseases.. SpringerPlus. 4:-. 2015
88. Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R.. Toxicology and applied pharmacology. 287:202-9. 2015
89. Gut feeling: MicroRNA discriminators of the intestinal TLR9-cholinergic links.. International immunopharmacology. 29:8-14. 2015
90. Abstracts from Rambam Research Day, December 11, 2014.. Rambam Maimonides medical journal. 2015
91. Corrigendum: Acute stress facilitates long-lasting changes in cholinergic gene expression.. Nature. 2015
92. Readthrough acetylcholinesterase (AChE-R) and regulated necrosis: pharmacological targets for the regulation of ovarian functions?. Cell death & disease. 2015
93. Fear and C-reactive protein cosynergize annual pulse increases in healthy adults.. Proceedings of the National Academy of Sciences of the United States of America. 112:E467-71. 2014
94. Whole transcriptome RNA sequencing data from blood leukocytes derived from Parkinson's disease patients prior to and following deep brain stimulation treatment.. Genomics data. 57-60. 2014
95. Novel roles of non-coding brain RNAs in health and disease.. Frontiers in molecular neuroscience. -. 2014
96. Competing targets of microRNA-608 affect anxiety and hypertension.. Human molecular genetics. 23:4569-80. 2014
97. Competing targets of microRNA-608 affect anxiety and hypertension.. Human molecular genetics. 23:4569-80. 2014
98. Emerging bioinformatics approaches for analysis of NGS-derived coding and non-coding RNAs in neurodegenerative diseases.. Frontiers in cellular neuroscience. -. 2014
99. Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing.. PLoS computational biology. 10:-. 2014
100. Global coevolution of human microRNAs and their target genes.. Molecular biology and evolution. 31:1237-47. 2014
101. Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.. Molecular medicine (Cambridge, Mass.). 20:38-45. 2014
102. Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders.. Frontiers in molecular neuroscience. -. 2014
103. A systems medicine clinical platform for understanding and managing non- communicable diseases.. Current pharmaceutical design. 2014
104. Competing targets of microRNA-608 affect anxiety and hypertension.. Human molecular genetics. 2014
105. MicroRNA therapeutics in neurological disease.. Current pharmaceutical design. 2014
106. MicroRNA therapeutics in neurological disease.. Current pharmaceutical design. 20:6022-7. 2014
107. Tumor necrosis factor-α and interleukin-6 concentrations in cerebrospinal fluid of dogs after seizures.. Journal of veterinary internal medicine. 2014
108. Overlapping molecular signatures in Parkinson's patients' leukocytes before and after treatment and in mouse model brain regions.. CNS & neurological disorders drug targets. 12:1086-93. 2013
109. AChE and RACK1 promote the anti-inflammatory properties of fluoxetine.. Journal of molecular neuroscience : MN. 53:306-15. 2013
110. Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease.. Journal of molecular neuroscience : MN. 53:298-305. 2013
111. Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.. The Journal of neuroscience : the official journal of the Society for Neuroscience. 33:14908-20. 2013
112. Acetylcholinesterase activity in the cerebrospinal fluid of dogs with seizures.. Veterinary journal (London, England : 1997). 198:292-4. 2013
113. Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson's patients leukocytes.. BMC genomics. -. 2013
114. Stereotactic injection of microRNA-expressing lentiviruses to the mouse hippocampus ca1 region and assessment of the behavioral outcome.. Journal of visualized experiments : JoVE. -. 2013
115. Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes.. Frontiers in molecular neuroscience. -. 2013
116. Statistically invalid classification of high throughput gene expression data.. Scientific reports. -. 2013
117. Alteration of the microRNA network during the progression of Alzheimer's disease.. EMBO molecular medicine. 2013
118. Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.. European journal of neurology. 2013
119. Hippocampal Lipocalin 2: an emotional link between neurons and glia.. Frontiers in Cellular Neuroscience. 2013
120. MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease.. Inflammatory bowel diseases. 2013
121. Overlapping molecular signatures in Parkinson's patients' leukocytes before and after treatment and in mouse model brain regions.. CNS & neurological disorders drug targets. 2013
122. Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load.. Current Alzheimer research. 2013
123. Sustained Alzheimer's amyloid pathology in myeloid differentiation protein-88-deficient APPswe/PS1 mice.. Neuro-degenerative diseases. 2013
124. microRNAs in nociceptive circuits as predictors of future clinical applications.. Frontiers in molecular neuroscience. 2013
125. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.. Molecular and cellular neurosciences. 436-46. 2012
126. Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4.. Proceedings of the National Academy of Sciences of the United States of America. 109:E3687-95. 2012
127. Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling.. Journal of cellular and molecular medicine. 16:2736-44. 2012
128. Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leucocytes.. Journal of cellular and molecular medicine. 16:1496-507. 2012
129. Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice.. EMBO molecular medicine. 4:730-42. 2012
130. Threshold-independent meta-analysis of Alzheimer's disease transcriptomes shows progressive changes in hippocampal functions, epigenetics and microRNA regulation.. Current Alzheimer research. 9:425-35. 2012
131. Stressing hematopoiesis and immunity: an acetylcholinesterase window into nervous and immune system interactions.. Frontiers in molecular neuroscience. -. 2012
132. Similar cation channels mediate protection from cerebellar exitotoxicity by exercise and inheritance.. Journal of cellular and molecular medicine. 16:555-68. 2012
133. Acetylcholinesterase loosens the brain's cholinergic anti-inflammatory response and promotes epileptogenesis.. Frontiers in molecular neuroscience. 2012
134. Acetylcholinesterase: old questions and new developments.. Frontiers in molecular neuroscience. 2012
135. Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis.. Epilepsia. 2012
136. Cholinergic involvement and manipulation approaches in multiple system disorders.. Chemico-biological interactions. 2012
137. Further developments with antisense treatment for myasthenia gravis.. Annals of the New York Academy of Sciences. 2012
138. Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target.. Brain structure & function. 2012
139. Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NFκB pathway.. Translational psychiatry. 2012
140. Threshold-independent meta-analysis of Alzheimer's disease transcriptomes shows progressive changes in hippocampal functions, epigenetics and microRNA regulation.. Current Alzheimer research. 2012
141. Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways.. Neurobiology of disease. 45:1018-30. 2011
142. Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.. PloS one. 6:-. 2011
143. Exon arrays reveal alternative splicing aberrations in Parkinson's disease leukocytes.. Neuro-degenerative diseases. 10:203-6. 2011
144. Adaptive alternative splicing correlates with less environmental risk of parkinsonism.. Neuro-degenerative diseases. 9:87-98. 2011
145. Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes.. Frontiers in molecular neuroscience. -. 2011
146. NeurimmiRs: microRNAs in the neuroimmune interface.. Trends in molecular medicine. 17:548-55. 2011
147. Butyrylcholinesterase interactions with amylin may protect pancreatic cells in metabolic syndrome.. Journal of cellular and molecular medicine. 2011
148. Cholinesterase modulations in patients with acute bacterial meningitis.. Scandinavian journal of clinical and laboratory investigation. 2011
149. Effects of physostigmine on microcirculatory alterations during experimental endotoxemia.. Shock (Augusta, Ga.). 2011
150. Letter by Shenhar-Tsarfaty et al regarding article, "Autonomic shift and increased susceptibility to infections after acute intracerebral hemorrhage".. Stroke. 2011
151. Nicotinic stimulation induces Tristetraprolin over-production and attenuates inflammation in muscle.. Biochimica et biophysica acta. 2011
152. Predictors for poststroke outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) study protocol.. International journal of stroke : official journal of the International Stroke Society. 2011
153. Quantum dot labeling of butyrylcholinesterase maintains substrate and inhibitor interactions and cell adherence features.. ACS chemical neuroscience. 2:141-50. 2010
154. It all starts at the ends: multifaceted involvement of C- and N-terminally modified cholinesterases in Alzheimer's disease.. Rambam Maimonides medical journal. 1:-. 2010
155. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.. Neurobiology of disease. 40:348-59. 2010
156. Acetylcholinesterase variants in Alzheimer's disease: from neuroprotection to programmed cell death.. Neuro-degenerative diseases. 7:60-3. 2010
157. Alanine-to-threonine substitutions and amyloid diseases: butyrylcholinesterase as a case study.. Chemico-biological interactions. 187:64-71. 2010
158. Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents.. Proceedings of the National Academy of Sciences of the United States of America. 2010
159. Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.. Molecular medicine (Cambridge, Mass.). 2010
160. Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase.. Plant biotechnology journal. 2010
161. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase.. Immunity. 31:965-73. 2009
162. Changes in brain MicroRNAs contribute to cholinergic stress reactions.. Journal of molecular neuroscience : MN. 40:47-55. 2009
163. Pro-apoptotic protein-protein interactions of the extended N-AChE terminus.. Journal of neural transmission (Vienna, Austria : 1996). 116:1435-42. 2009
164. The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.. The Journal of biological chemistry. 284:17170-17179. 2009
165. A network-based method for predicting disease-causing genes.. Journal of computational biology : a journal of computational molecular cell biology. 2009
166. Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain.. Brain, behavior, and immunity. 2009
167. Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA.. The Journal of biological chemistry. 2009
168. Stress-induced alternative splicing modulations in brain and periphery: acetylcholinesterase as a case study.. Annals of the New York Academy of Sciences. 269-81. 2008
169. N-acetylcholinesterase-induced apoptosis in Alzheimer's disease.. PloS one. 3:-. 2008
170. Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients.. Journal of neuroimmunology. 227-36. 2008
171. Identifying alternative hyper-splicing signatures in MG-thymoma by exon arrays.. PloS one. 3:-. 2008
172. Alternate AChE-R variants facilitate cellular metabolic activity and resistance to genotoxic stress through enolase and RACK1 interactions.. Chemico-biological interactions. 175:11-21. 2008
173. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats.. The European journal of neuroscience. 27:965-75. 2008
174. Acetylcholine-induced seizure-like activity and modified cholinergic gene expression in chronically epileptic rats.. The European journal of neuroscience. 27:965-75. 2008
175. Introduction: cholinesterases, from molecular complexity to non-hydrolytic functions.. The FEBS journal. 275:-. 2008
176. Acetylcholinesterase-R increases germ cell apoptosis but enhances sperm motility.. Journal of cellular and molecular medicine. 2008
177. Antisense treatment for myasthenia gravis: experience with monarsen.. Annals of the New York Academy of Sciences. 2008
178. Human recombinant butyrylcholinesterase purified from the milk of transgenic goats interacts with beta-amyloid fibrils and suppresses their formation in vitro.. Neuro-degenerative diseases. 2008
179. Nicotine relieves anxiogenic-like behavior in mice that overexpress the read-through variant of acetylcholinesterase but not in wild-type mice.. Molecular pharmacology. 2008
180. The role of the read through variant of acetylcholinesterase in anxiogenic effects of predator stress in mice.. Behavioural brain research. 2008
181. The structural basis of amyloid formation.. Current Alzheimer research. 2008
182. Transgenic inactivation of acetylcholinesterase impairs homeostasis in mouse hippocampal granule cells.. Hippocampus. 2008
183. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.. Brain : a journal of neurology. 131:109-19. 2007
184. Cytokines and cholinergic signals co-modulate surgical stress-induced changes in mood and memory.. Brain, behavior, and immunity. 22:388-98. 2007
185. Cholinergic status modulations in human volunteers under acute inflammation.. Journal of molecular medicine (Berlin, Germany). 85:1239-51. 2007
186. It is all about resolution. Meeting report based upon presentations at the 10th International Global BioMillennium 2006 symposium on molecular cell biology (Tbilisi, Georgia).. The FEBS journal. 274:924-7. 2007
187. The thymic theme of acetylcholinesterase splice variants in myasthenia gravis.. Blood. 109:4383-91. 2007
188. A novel isoform of acetylcholinesterase exacerbates photoreceptors death after photic stress.. Investigative ophthalmology & visual science. 2007
189. Acetylcholinesterase activity in veterans of the first Gulf War.. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2007
190. Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia.. Leukemia. 2007
191. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.. Brain : a journal of neurology. 2007
192. Cholinergic status modulations in human volunteers under acute inflammation.. Journal of molecular medicine (Berlin, Germany). 2007
193. Cytokines and cholinergic signals co-modulate surgical stress-induced changes in mood and memory.. Brain, behavior, and immunity. 2007
194. Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection.. The European journal of neuroscience. 2007
195. Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection.. The European journal of neuroscience. 25:87-98. 2007
196. It is all about resolution. Meeting report based upon presentations at the 10th International Global BioMillennium 2006 symposium on molecular cell biology (Tbilisi, Georgia).. The FEBS journal. 2007
197. Peripheral site acetylcholinesterase blockade induces RACK1-associated neuronal remodeling.. Neuro-degenerative diseases. 2007
198. Peripheral site acetylcholinesterase blockade induces RACK1-associated neuronal remodeling.. Neuro-degenerative diseases. 4:171-84. 2007
199. Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2007
200. Readthrough acetylcholinesterase in inflammation-associated neuropathies.. Life sciences. 2007
201. The thymic theme of acetylcholinesterase splice variants in myasthenia gravis.. Blood. 2007
202. Translational control of recombinant human acetylcholinesterase accumulation in plants.. BMC biotechnology. 2007
203. Treatment of human myasthenia gravis with oral antisense suppression of acetylcholinesterase.. Neurology. 2007
204. Adaptive changes in acetylcholinesterase gene expression as mediators of recovery from chemical and biological insults.. Toxicology. 233:97-107. 2006
205. Acetylcholinesterase modulates stress-induced motor responses through catalytic and noncatalytic properties.. Biological psychiatry. 60:741-51. 2006
206. Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 20:1733-5. 2006
207. Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission.. Cell and tissue research. 326:655-69. 2006
208. Butyrylcholinesterase attenuates amyloid fibril formation in vitro.. Proceedings of the National Academy of Sciences of the United States of America. 103:8628-33. 2006
209. Modulated splicing-associated gene expression in P19 cells expressing distinct acetylcholinesterase splice variants.. Journal of neurochemistry. 24-34. 2006
210. RACK1 has the nerve to act: structure meets function in the nervous system.. Progress in neurobiology. 78:117-34. 2006
211. ACHE gene expression in human brain tumors involves alternative splicing and CREB-induced proliferative signals.. The Israel Medical Association journal : IMAJ. 2006
212. ARP, the cleavable C-terminal peptide of "readthrough" acetylcholinesterase, promotes neuronal development and plasticity.. Journal of molecular neuroscience : MN. 2006
213. Acetylcholinesterase modulates stress-induced motor responses through catalytic and noncatalytic properties.. Biological psychiatry. 2006
214. Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.. The European journal of neuroscience. 2006
215. Adaptive changes in acetylcholinesterase gene expression as mediators of recovery from chemical and biological insults.. Toxicology. 2006
216. Butyrylcholinesterase attenuates amyloid fibril formation in vitro.. Proceedings of the National Academy of Sciences of the United States of America. 2006
217. Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2006
218. Gene-environment interactions in sporadic Parkinson's disease.. Journal of neurochemistry. 2006
219. Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses.. Journal of immunology (Baltimore, Md. : 1950). 2006
220. Modulated splicing-associated gene expression in P19 cells expressing distinct acetylcholinesterase splice variants.. Journal of neurochemistry. 2006
221. Neuromuscular therapeutics by RNA-targeted suppression of ACHE gene expression.. Annals of the New York Academy of Sciences. 2006
222. RACK1 has the nerve to act: structure meets function in the nervous system.. Progress in neurobiology. 2006
223. Readthrough acetylcholinesterase: a multifaceted inducer of stress reactions.. Journal of molecular neuroscience : MN. 2006
224. Readthrough acetylcholinesterase: a multifaceted inducer of stress reactions.. Journal of molecular neuroscience : MN. 30:197-200. 2006
225. Termination and beyond: acetylcholinesterase as a modulator of synaptic transmission.. Cell and tissue research. 2006
226. Virtues and woes of AChE alternative splicing in stress-related neuropathologies.. Trends in neurosciences. 2006
227. MicroRNA modulation of megakaryoblast fate involves cholinergic signaling.. Leukemia research. 30:583-95. 2005
228. Chronic cholinergic imbalances promote brain diffusion and transport abnormalities.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 19:910-22. 2005
229. Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production.. Annals of neurology. 57:741-5. 2005
230. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.. Journal of neurochemistry. 92:1216-27. 2005
231. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 19:452-4. 2005
232. Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production.. Annals of neurology. 2005
233. Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2005
234. Cellular stress reactions as putative cholinergic links in Alzheimer's disease.. Neurochemical research. 2005
235. Cellular stress reactions as putative cholinergic links in Alzheimer's disease.. Neurochemical research. 30:909-19. 2005
236. Characterizing pea acetylcholinesterase.. Chemico-biological interactions. 2005
237. Chronic cholinergic imbalances promote brain diffusion and transport abnormalities.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2005
238. Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development.. Cerebral cortex (New York, N.Y. : 1991). 2005
239. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.. Journal of neurochemistry. 2005
240. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice.. Current Alzheimer research. 2005
241. MicroRNA modulation of megakaryoblast fate involves cholinergic signaling.. Leukemia research. 2005
242. Muscarinic modulations of neuronal anticholinesterase responses.. Chemico-biological interactions. 2005
243. Purification of transgenic plant-derived recombinant human acetylcholinesterase-R.. Chemico-biological interactions. 2005
244. RNA-targeted suppression of stress-induced allostasis in primate spinal cord neurons.. Neuro-degenerative diseases. 2005
245. RNA-targeted suppression of stress-induced allostasis in primate spinal cord neurons.. Neuro-degenerative diseases. 2:16-27. 2005
246. SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA.. Molecular psychiatry. 2005
247. Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis.. Blood. 2005
248. Blood-cell-specific acetylcholinesterase splice variations under changing stimuli.. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. 22:523-31. 2004
249. From brain to blood: alternative splicing evidence for the cholinergic basis of Mammalian stress responses.. Annals of the New York Academy of Sciences. 85-98. 2004
250. Combinatorial complexity of 5' alternative acetylcholinesterase transcripts and protein products.. The Journal of biological chemistry. 279:29740-51. 2004
251. Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study.. Proceedings of the National Academy of Sciences of the United States of America. 101:5512-7. 2004
252. Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study.. Proceedings of the National Academy of Sciences of the United States of America. 2004
253. Blood-cell-specific acetylcholinesterase splice variations under changing stimuli.. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. 2004
254. CREB regulates AChE-R-induced proliferation of human glioblastoma cells.. Neoplasia (New York, N.Y.). 2004
255. CREB regulates AChE-R-induced proliferation of human glioblastoma cells.. Neoplasia (New York, N.Y.). 6:279-86. 2004
256. Combinatorial complexity of 5' alternative acetylcholinesterase transcripts and protein products.. The Journal of biological chemistry. 2004
257. Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons.. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2004
258. From brain to blood: alternative splicing evidence for the cholinergic basis of Mammalian stress responses.. Annals of the New York Academy of Sciences. 2004
259. Function of alternative splicing.. Gene. 2004
260. Identifying subtle interrelated changes in functional gene categories using continuous measures of gene expression.. Bioinformatics (Oxford, England). 2004
261. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.. Journal of neurochemistry. 2004
262. Organophosphate risk of leukemogenesis.. Leukemia research. 2004
263. Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation.. Molecular psychiatry. 2004
264. Tissue distribution of cholinesterases and anticholinesterases in native and transgenic tomato plants.. Plant molecular biology. 2004
265. Ethics, public policy and behavioral genetics.. The Israel Medical Association journal : IMAJ. 5:83-6. 2003
266. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 17:214-22. 2003
267. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex.. Neurobiology of aging. 2003
268. Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology.. The Journal of physiology. 2003
269. Chronic acetylcholinesterase overexpression induces multilevelled aberrations in mouse neuromuscular physiology.. The Journal of physiology. 546:165-73. 2003
270. Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase.. Journal of molecular neuroscience : MN. 2003
271. Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase.. Journal of molecular neuroscience : MN. 21:199-212. 2003
272. Ethics, public policy and behavioral genetics.. The Israel Medical Association journal : IMAJ. 2003
273. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2003
274. Interaction of "readthrough" acetylcholinesterase with RACK1 and PKCbeta II correlates with intensified fear-induced conflict behavior.. Proceedings of the National Academy of Sciences of the United States of America. 100:283-8. 2002
275. Complex regulation of acetylcholinesterase gene expression in human brain tumors.. Oncogene. 21:8428-41. 2002
276. Pre-mRNA splicing modulations in senescence.. Aging cell. 1:10-6. 2002
277. Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements.. European journal of biochemistry. 269:3607-18. 2002
278. Runx1/AML1 in leukemia: disrupted association with diverse protein partners.. Leukemia research. 26:221-8. 2002
279. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity.. Science (New York, N.Y.). 295:508-12. 2002
280. Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity.. Science (New York, N.Y.). 2002
281. Complex regulation of acetylcholinesterase gene expression in human brain tumors.. Oncogene. 2002
282. Defects in pre-mRNA processing as causes of and predisposition to diseases.. DNA and cell biology. 2002
283. Development of human antibody fragments directed towards synaptic acetylcholinesterase using a semi-synthetic phage display library.. Journal of neural transmission. Supplementum. 2002
284. Interaction of "readthrough" acetylcholinesterase with RACK1 and PKCbeta II correlates with intensified fear-induced conflict behavior.. Proceedings of the National Academy of Sciences of the United States of America. 2002
285. Neuronal overexpression of "readthrough" acetylcholinesterase is associated with antisense-suppressible behavioral impairments.. Molecular psychiatry. 2002
286. Pre-mRNA splicing modulations in senescence.. Aging cell. 2002
287. Runx1/AML1 in leukemia: disrupted association with diverse protein partners.. Leukemia research. 2002
288. Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.. Neurology. 2002
289. The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation.. Experimental hematology. 2002
290. Transcriptional regulation of erythropoiesis. Fine tuning of combinatorial multi-domain elements.. European journal of biochemistry. 2002
291. Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.. Journal of molecular neuroscience : MN. 2002
292. ARP, a peptide derived from the stress-associated acetylcholinesterase variant, has hematopoietic growth promoting activities.. Molecular medicine (Cambridge, Mass.). 2001
293. Acetylcholinesterase--new roles for an old actor.. Nature reviews. Neuroscience. 2001
294. Changes in neuronal acetylcholinesterase gene expression and division of labor in honey bee colonies.. Journal of molecular neuroscience : MN. 2001
295. Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase.. Journal of neurochemistry. 2001
296. Complex host cell responses to antisense suppression of ACHE gene expression.. Antisense & nucleic acid drug development. 2001
297. Expression of recombinant human acetylcholinesterase in transgenic tomato plants.. Biotechnology and bioengineering. 2001
298. Frequent blood-brain barrier disruption in the human cerebral cortex.. Cellular and molecular neurobiology. 2001
299. Genomic dissection reveals locus response to stress for mammalian acetylcholinesterase.. Cellular and molecular neurobiology. 2001
300. Modified testicular expression of stress-associated "readthrough" acetylcholinesterase predicts male infertility.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2001
301. The leukemic effect of anticholinesterases.. Leukemia research. 2001
302. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases.. Human molecular genetics. 2000
303. Anti-sense approach to anticholinesterase therapeutics.. The Israel Medical Association journal : IMAJ. 2000
304. Antisense prevention of neuronal damages following head injury in mice.. Journal of molecular medicine (Berlin, Germany). 2000
305. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers.. Molecular medicine (Cambridge, Mass.). 2000
306. Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates.. Proceedings of the National Academy of Sciences of the United States of America. 2000
307. Genomic and transcriptional characterization of the human ACHE locus: complex involvement with acquired and inherited diseases.. The Israel Medical Association journal : IMAJ. 2000
308. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.. European journal of pharmacology. 2000
309. Synaptogenesis and myopathy under acetylcholinesterase overexpression.. Journal of molecular neuroscience : MN. 2000
310. Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission.. Chemico-biological interactions. 1999
311. Antisense technologies have a future fighting neurodegenerative diseases.. Antisense & nucleic acid drug development. 1999
312. Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine.. Clinical and experimental pharmacology & physiology. 1999
313. Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3' alternative splicing variant of acetylcholinesterase.. Molecular and cellular biology. 1999
314. Manipulations of ACHE gene expression suggest non-catalytic involvement of acetylcholinesterase in the functioning of mammalian photoreceptors but not in retinal degeneration.. Brain research. Molecular brain research. 1999
315. Neurobiology.. IDrugs : the investigational drugs journal. 1999
316. Structural roles of acetylcholinesterase variants in biology and pathology.. European journal of biochemistry. 1999
317. Tracking cholinergic pathways from psychological and chemical stressors to variable neurodeterioration paradigms.. Current opinion in neurology. 1999
318. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini.. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1998
319. Acute stress facilitates long-lasting changes in cholinergic gene expression.. Nature. 1998
320. Cholinergic excitation induces activity-dependent electrophysiological and transcriptional responses in hippocampal slices.. Journal of physiology, Paris. 1998
321. Cholinergic mechanisms--tenth international symposium. 1-5 September 1998, Arcachon, France.. IDrugs : the investigational drugs journal. 1998
322. Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis.. Proceedings of the National Academy of Sciences of the United States of America. 1998
323. In vivo and in vitro resistance to multiple anticholinesterases in Xenopus laevis tadpoles.. Toxicology letters. 1998
324. Position effect variegations and brain-specific silencing in transgenic mice overexpressing human acetylcholinesterase variants.. Journal of physiology, Paris. 1998
325. Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact.. Neurochemistry international. 1998
326. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration.. Proceedings of the National Academy of Sciences of the United States of America. 1997
327. Differentiation intensifies the susceptibility of pheochromocytoma cells to antisense oligodeoxynucleotide-dependent suppression of acetylcholinesterase activity.. Antisense & nucleic acid drug development. 1997
328. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice.. Journal of neurochemistry. 1997
329. Genetic manipulations of cholinergic communication reveal trans-acting control mechanisms over acetylcholine receptors.. Journal of receptor and signal transduction research. 1997
330. Immature human megakaryocytes produce nuclear-associated acetylcholinesterase.. Blood. 1997
331. In vitro phosphorylation of acetylcholinesterase at non-consensus protein kinase A sites enhances the rate of acetylcholine hydrolysis.. Brain research. Molecular brain research. 1997
332. Normal and atypical butyrylcholinesterases in placental development, function, and malfunction.. Cellular and molecular neurobiology. 1997
333. Probing accessible sites for ribozymes on human acetylcholinesterase RNA.. RNA (New York, N.Y.). 1997
334. Cholinergic drug resistance and impaired spatial learning in transgenic mice overexpressing human brain acetylcholinesterase.. Progress in brain research. 1996
335. Murine and human mast cell express acetylcholinesterase.. FEBS letters. 1996
336. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells.. Journal of neurochemistry. 1996
337. Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.. Molecular pharmacology. 1996
338. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response.. Nature medicine. 1996
339. Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons.. Pharmacology & therapeutics. 1995
340. Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers.. Nature medicine. 1995
341. HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumors.. Gynecologic oncology. 1995
342. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants.. Brain research. Molecular brain research. 1995
343. Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3'-terminal exons.. Molecular and cellular biology. 1995
344. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice.. Current biology : CB. 1995
345. Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo.. Gene therapy. 1994
346. Antisense inhibition of butyrylcholinesterase gene expression predicts adverse hematopoietic consequences to cholinesterase inhibitors.. Cellular and molecular neurobiology. 1994
347. Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo.. Proceedings of the National Academy of Sciences of the United States of America. 1994
348. Cholinotoxic effects on acetylcholinesterase gene expression are associated with brain-region specific alterations in G,C-rich transcripts.. Brain research. 1994
349. Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins.. Experimental cell research. 1994
350. Mutations and impaired expression in the ACHE and BCHE genes: neurological implications.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 1994
351. Overexpressed monomeric human acetylcholinesterase induces subtle ultrastructural modifications in developing neuromuscular junctions of Xenopus laevis embryos.. Journal of neurochemistry. 1994
352. Population diversity and distinct haplotype frequencies associated with ACHE and BCHE genes of Israeli Jews from trans-Caucasian Georgia and from Europe.. Genomics. 1994
353. Site-directed mutagenesis of active site residues reveals plasticity of human butyrylcholinesterase in substrate and inhibitor interactions.. Journal of neurochemistry. 1994
354. Testicular amplification and impaired transmission of human butyrylcholinesterase cDNA in transgenic mice.. Human reproduction (Oxford, England). 1994
355. Transgenic engineering of neuromuscular junctions in Xenopus laevis embryos transiently overexpressing key cholinergic proteins.. Proceedings of the National Academy of Sciences of the United States of America. 1994
356. Use of partially phosphorothioated "antisense" oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis in culture.. Antisense research and development. 1994
357. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.. Journal of molecular biology. 1993
358. Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos.. Proceedings of the National Academy of Sciences of the United States of America. 1993
359. Molecular dissection of cholinesterase domains responsible for carbamate toxicity.. Chemico-biological interactions. 1993
360. Promoter elements and alternative splicing in the human ACHE gene.. Progress in brain research. 1993
361. Structure-function relationship studies in human cholinesterases reveal genomic origins for individual variations in cholinergic drug responses.. Progress in neuro-psychopharmacology & biological psychiatry. 1993
362. Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis.. Proceedings of the National Academy of Sciences of the United States of America. 1992
363. Excavations into the active-site gorge of cholinesterases.. Trends in biochemical sciences. 1992
364. In vivo gene amplification in non-cancerous cells: cholinesterase genes and oncogenes amplify in thrombocytopenia associated with lupus erythematosus.. Mutation research. 1992
365. Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.. The EMBO journal. 1992
366. Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries.. Genomics. 1992
367. X inactivation in mammalian testis is correlated with inactive X-specific transcription.. Nature genetics. 1992
368. Xenopus oocyte microinjection: from gene to protein.. Methods in enzymology. 1992
369. [Medical aspects and structural implications of cholinesterase inhibitors]. Harefuah. 1992
370. A role for cholinesterases in tumorigenesis?. Cancer cells (Cold Spring Harbor, N.Y. : 1989). 1991
371. Chorionic villus cDNA library displays expression of butyrylcholinesterase: putative genetic disposition for ecological danger.. Prenatal diagnosis. 1991
372. Human acetylcholinesterase and butyrylcholinesterase are encoded by two distinct genes.. Cellular and molecular neurobiology. 1991
373. Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas.. The Journal of clinical investigation. 1990
374. Amplification of butyrylcholinesterase and acetylcholinesterase genes in normal and tumor tissues: putative relationship to organophosphorous poisoning.. Pharmaceutical research. 1990
375. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.. The Journal of biological chemistry. 1990
376. Aspartate-70 to glycine substitution confers resistance to naturally occurring and synthetic anionic-site ligands on in-ovo produced human butyrylcholinesterase.. Journal of neuroscience research. 1990
377. Coinjection of Xenopus oocytes with cDNA-produced and native mRNAs: a molecular biological approach to the tissue-specific processing of human cholinesterases.. International review of neurobiology. 1990
378. Expression and in vivo amplification of the human acetylcholinesterase and butyrylcholinesterase genes.. Progress in brain research. 1990
379. Expression of alternatively terminated unusual human butyrylcholinesterase messenger RNA transcripts, mapping to chromosome 3q26-ter, in nervous system tumors.. Cancer research. 1990
380. Improving poor in vitro transcription from G,C-rich genes.. Nucleic acids research. 1990
381. Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.. Molecular and cellular biology. 1990
382. Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure.. Proceedings of the National Academy of Sciences of the United States of America. 1990
383. [Gene amplification in tumors]. Harefuah. 1990
384. Cholinoceptive properties of human primordial, preantral, and antral oocytes: in situ hybridization and biochemical evidence for expression of cholinesterase genes.. Journal of molecular neuroscience : MN. 1989
385. Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis.. Proceedings of the National Academy of Sciences of the United States of America. 1989
386. De novo amplification within a "silent" human cholinesterase gene in a family subjected to prolonged exposure to organophosphorous insecticides.. Proceedings of the National Academy of Sciences of the United States of America. 1989
387. Definition, at the molecular level, of a thyroglobulin-acetylcholinesterase shared epitope: study of its pathophysiological significance in patients with Graves' ophthalmopathy.. Autoimmunity. 1989
388. Efficient functioning of plant promoters and poly(A) sites in Xenopus oocytes.. Nucleic acids research. 1989
389. Expression and tissue-specific assembly of human butyrylcholine esterase in microinjected Xenopus laevis oocytes.. The Journal of biological chemistry. 1989
390. Gene mapping on chorionic villi chromosomes by hybridization in situ: localization of cholinesterase cDNA binding sites to chromosomes 3q21, 3q26-ter and 16q21.. Human reproduction (Oxford, England). 1989
391. Sequence similarities between human acetylcholinesterase and related proteins: putative implications for therapy of anticholinesterase intoxication.. Progress in clinical and biological research. 1989
392. Tissue-specific processing and polarized compartmentalization of clone-produced cholinesterase in microinjected Xenopus oocytes.. Cellular and molecular neurobiology. 1989
393. [In-situ hybridization on chorionic villi chromosomes]. Harefuah. 1989
394. trans activation of rat phosphoenolpyruvate carboxykinase (GTP) gene expression by micro-coinjection of rat liver mRNA in Xenopus laevis oocytes.. Molecular and cellular biology. 1989
395. Antibodies against acetylcholinesterase and low levels of cholinesterases in a patient with an atypical neuromuscular disorder.. Clinical immunology and immunopathology. 1988
396. Biosynthesis of catalytically active rat testosterone 5 alpha-reductase in microinjected Xenopus oocytes: evidence for tissue-specific differences in translatable mRNA.. Proceedings of the National Academy of Sciences of the United States of America. 1988
397. Cross-homologies and structural differences between human cholinesterases revealed by antibodies against cDNA-produced human butyrylcholinesterase peptides.. Journal of neurochemistry. 1988
398. Modified properties of serum cholinesterases in primary carcinomas.. Cancer. 1988
399. Synthesis and localization of plasma proteins in the developing human brain. Integrity of the fetal blood-brain barrier to endogenous proteins of hepatic origin.. Developmental biology. 1988
400. Expression of cholinesterase genes in human oocytes revealed by in-situ hybridization.. Human reproduction (Oxford, England). 1987
401. Human cholinesterase genes localized by hybridization to chromosomes 3 and 16.. Human genetics. 1987
402. Isolation and characterization of full-length cDNA clones coding for cholinesterase from fetal human tissues.. Proceedings of the National Academy of Sciences of the United States of America. 1987
403. Molecular biological search for human genes encoding cholinesterases.. Molecular neurobiology. 1987
404. Molecular cloning of human cholinesterase genes: potential applications in neurotoxicology.. Progress in clinical and biological research. 1987
405. Are the effects of gestational stress on motor development and cerebellar cholinesterase activity mediated prenatally?. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience. 1986
406. Divergent regulation of muscarinic binding sites and acetylcholinesterase in discrete regions of the developing human fetal brain.. Cellular and molecular neurobiology. 1986
407. Synthesis of plasma proteins in fetal, adult, and neoplastic human brain tissue.. Developmental biology. 1986
408. The use of mRNA translation in vitro and in ovo followed by crossed immunoelectrophoretic autoradiography to study the biosynthesis of human cholinesterases.. Cellular and molecular neurobiology. 1986
409. Use of synthetic oligodeoxynucleotide probes for the isolation of a human cholinesterase cDNA clone.. Journal of neuroscience research. 1986
410. A human acetylcholinesterase gene identified by homology to the Ace region of Drosophila.. Proceedings of the National Academy of Sciences of the United States of America. 1985
411. Amplification and overexpression of the EGF receptor gene in primary human glioblastomas.. Journal of cell science. Supplement. 1985
412. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.. Nature. 1985
413. Expression of acetylcholinesterase gene(s) in the human brain: molecular cloning evidence for cross-homologous sequences.. Journal de physiologie. 1985
414. Messenger ribonucleic acid (mRNA) from developing rat cerebellum directs in vitro synthesis of plasma proteins.. Brain research. 1985
415. Polymorphism of acetylcholinesterase in discrete regions of the developing human fetal brain.. Journal of neurochemistry. 1985
416. The biosynthesis of biologically active proteins in mRNA-microinjected Xenopus oocytes.. CRC critical reviews in biochemistry. 1985
417. Characterization of activities and forms of cholinesterases in human primary brain tumors.. Experimental neurology. 1984
418. Expression of cholinesterase gene(s) in human brain tissues: translational evidence for multiple mRNA species.. The EMBO journal. 1984
419. Expression of epidermal growth factor receptors in human brain tumors.. Cancer research. 1984
420. Expression of muscarinic binding sites in primary human brain tumors.. Brain research. 1984
421. Production of EGF-containing polypeptides in Xenopus oocytes microinjected with submaxillary gland mRNA.. The EMBO journal. 1984
422. A microfluorometric assay for cholinesterases, suitable for multiple kinetic determinations of picomoles of released thiocholine.. Analytical biochemistry. 1983
423. Biosynthesis of acetylcholinesterase in rat brain and Torpedo electric organ is directed by scarce mRNA species.. Progress in brain research. 1983
424. Estrogen-induced creatine kinase in the reproductive system of the immature female rat.. Endocrinology. 1983
425. Modified composition of major ontogenetically regulated mRNAs and proteins in the cerebellum of old and of staggerer mice.. Brain research. 1983
426. Modulation in the levels and localization of plasminogen activator in differentiating neuroblastoma cells.. Brain research. 1983
427. Plasminogen activator in the developing rat cerebellum: biosynthesis and localization in granular neurons.. Brain research. 1983
428. Synthetic leader peptide modulates secretion of proteins from microinjected Xenopus oocytes.. Proceedings of the National Academy of Sciences of the United States of America. 1983
429. Altered ontogenesis of muscarinic receptors in agranular cerebellar cortex.. Journal of neurochemistry. 1982
430. Biosynthesis and secretion of catalytically active acetylcholinesterase in Xenopus oocytes microinjected with mRNA from rat brain and from Torpedo electric organ.. Proceedings of the National Academy of Sciences of the United States of America. 1982
431. Degranulation of rat cerebellum induces selective variations in gene expression.. Journal of neurochemistry. 1982
432. Increase in the translatable mRNA for acetylcholine receptor during embryonic development of Torpedo ocellata electric organ.. FEBS letters. 1982
433. Plasminogen activator is enriched in the synaptosomal plasma membranes.. Brain research. 1982
434. The regulatory function of poly(A) and adjacent 3' sequences in translated RNA.. Progress in nucleic acid research and molecular biology. 1982
435. Variations in gene expression during development of the rat cerebellum.. Brain research. 1982
436. Microinjected Xenopus oocytes synthesize active human plasminogen activator.. Nucleic acids research. 1981
437. Plasminogen activator in the rodent brain.. Brain research. 1981
438. Secreted proteins in the medium of microinjected Xenopus oocytes are degraded by oocyte proteases.. FEBS letters. 1981
439. Sensitive autoradiographic quantification of electrophoretically separated proteases.. Analytical biochemistry. 1981
440. Translational activity and functional stability of human fibroblast beta 1 and beta 2 interferon mRNAs lacking 3'-terminal RNA sequences.. Proceedings of the National Academy of Sciences of the United States of America. 1981
441. Rate of synthesis and concentration of specific mRNA sequences in cultured Chinese hamster ovary cells compared to liver cells.. Biochemical and biophysical research communications. 1980
442. Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies.. Proceedings of the National Academy of Sciences of the United States of America. 1980
443. Rat growth hormone gene: intervening sequences separate the mRNA regions.. Nucleic acids research. 1979
444. Recognition of messenger RNA in eukaryotic protein synthesis. Equilibrium studies of the interaction between messenger RNA and the initiation factor that binds methionyl-tRNAf.. European journal of biochemistry. 1979
445. Does 3'-terminal poly(A) stabilize human fibroblast interferon mRNA in oocytes of Xenopus laevis?. Proceedings of the National Academy of Sciences of the United States of America. 1978
446. Translation in vitro of carnation mottle virus RNA. Regulatory function of the 3'-region.. Virology. 1978
447. Degradation of deadenylated rabbit alpha-globin mRNA in Xenopus oocytes is associated with its translation.. Nature. 1977
448. Initiation of RNA synthesis in isolated nuclei.. European journal of biochemistry. 1977
449. Membrane associated cytoplasmic mRNA in Artemia salina; functional and physical changes during development.. Nucleic acids research. 1977
450. Purification and characterization of polynucleotide phosphorylase from Escherichia coli. Probe for the analysis of 3' sequences of RNA.. The Journal of biological chemistry. 1977
451. Role of the polyadenylate sequence in the stability of globin messenger RNA injected into Xenopus oocytes.. Acta biologica et medica Germanica. 1977
452. Enzymatic acylation of histidine to tobacco mosaic virus RNA.. Virology. 1976
453. Globin mRNA species containing poly(A) segments of different lengths. Their functional stability in Xenopus oocytes.. European journal of biochemistry. 1976
454. Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes.. Proceedings of the National Academy of Sciences of the United States of America. 1975
455. Proceedings: Enzymatic acylation of histidine to tobacco mosaic virus RNA.. Israel journal of medical sciences. 1975
456. Proceedings: Role of the polyadenylic segment in the translation of globin messenger RNA.. Israel journal of medical sciences. 1975
457. Proceedings: The polyadenylic segment of globin messenger RNA ensures its stability in vivo.. Archives internationales de physiologie et de biochimie. 1975
458. Readenylation of polyadenylate-free globin messenger RNA restores its stability in vivo.. European journal of biochemistry. 1975
459. [Proceedings: Accelerated degradation of globin messenger RNA after removal of polyadenylic segment in Xenopus oocytes]. Archives internationales de physiologie et de biochimie. 1975
460. In vitro translation of polyadenylic acid-free rabbit globin messenger RNA.. Journal of molecular biology. 1974
461. Proceedings: Role of the polyadenylic segment in the translation of globin messenger RNA.. Hoppe-Seyler's Zeitschrift fur physiologische Chemie. 1974
462. Proceedings: Role of the polyadenylic segment in the translation of globin messenger RNA.. Hoppe-Seyler's Zeitschrift fur physiologische Chemie. 1974
463. Role of the polyadenylate segment in the translation of globin messenger RNA in Xenopus oocytes.. Proceedings of the National Academy of Sciences of the United States of America. 1974
464. Inducible and constitutive -galactosidase formation in cells recovering from protein synthesis inhibition.. Journal of bacteriology. 1971
document